Assignee
FUJIREBIO DIAGNOSTICS INC
US·0 granted patents·8 pending applications·0 citations·filing 2003–2024
Top patents by PatentIndex Score
8 records- 0182US2024288434A1Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancersFUJIREBIO DIAGNOSTICS INC·Filed 2024·Application pending·0 cites
- 0281US2024230652A9Use of he4 and other biochemical markers for assessment of ovarian cancersFUJIREBIO DIAGNOSTICS INC·Filed 2023·Application pending·0 cites
- 0365US2020182878A1Use of he4 and other biochemical markers for assessment of ovarian cancersFUJIREBIO DIAGNOSTICS INC·Filed 2020·Application pending·0 cites
- 0465US2020292549A1Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancersFUJIREBIO DIAGNOSTICS INC·Filed 2020·Application pending·0 cites
- 0543US2004180387A1Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancerFUJIREBIO DIAGNOSTICS INC·Filed 2003·Application pending·0 cites
- 0642US2006014221A1Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesotheliomaFUJIREBIO DIAGNOSTICS INC·Filed 2005·Application pending·0 cites
- 0737US2006014211A1Detection of mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of the peritoneum and the peritoneal cavityFUJIREBIO DIAGNOSTICS INC·Filed 2005·Application pending·0 cites
- 0836US2020254112A1Antibody conjugation methodFUJIREBIO DIAGNOSTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when FUJIREBIO DIAGNOSTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →